Skip to content
Shiv Rao, co-founder and CEO of AbridgeAbridgeSan Francisco, USA
Website

Abridge CEO Shiv Rao: Email Address, LinkedIn and Bio (2026)

Curated by Khrystyna Oleksiienko · Published

Shiv Rao, MD, is the co-founder and CEO of Abridge, the healthcare AI company last valued at a reported $5.3 billion, and a practicing cardiologist at UPMC. He doesn’t publish a personal email; he is on LinkedIn and on X as @ShivdevRao.

Company overview

Company
Abridge AI, Inc. (Delaware)
Industry
Healthcare AI: clinical documentation and clinician intelligence
Founded
2018
Headquarters
San Francisco, USA
Revenue
Not disclosed; $117M contracted ARR reported for Q1 2025
Funding stage
Series E at a reported $5.3B (Jun 2025); Eli Lilly strategic investment (Jun 2026)

Shiv Rao, MD, is the co-founder and CEO of Abridge, the healthcare AI company last valued at a reported $5.3 billion (June 2025). A practicing cardiologist at UPMC, he started it in February 2018. He doesn’t publish a personal email address; his public channels are LinkedIn and X, and Abridge’s media inbox is press@abridge.com.

Shiv Rao at a glance

Fact

Detail

Full name

Shivdev (Shiv) Rao, MD

Role

Co-founder and CEO of Abridge since 2018

Also

Practicing cardiologist at UPMC

Education

BA, Carnegie Mellon; medical education and training at the University of Michigan and the University of Pittsburgh School of Medicine

Based in

Pittsburgh, commuting to San Francisco

Age

Not published by a reliable source

Net worth

No Forbes or Bloomberg estimate

Email

Not published; press@abridge.com for media

LinkedIn

linkedin.com/in/shivdevrao

X

@ShivdevRao

Abridge CEO email address: how to reach Shiv Rao

Rao doesn’t publish a personal email address, and Abridge doesn’t publish one for him. He is on LinkedIn, with about 19,000 followers, and on X. Abridge’s official inboxes are below.

Channel

Address

Note

LinkedIn

linkedin.com/in/shivdevrao

About 19,000 followers

X

@ShivdevRao

About 4,000 followers

Press

press@abridge.com

Abridge’s media inbox

Sales

sales@abridge.com

Sales inquiries

Privacy

privacy@abridge.com

Privacy and data requests

Website

abridge.com/contact

Contact form

Need verified CEO emails at scale? The LeadWave AI companies email list has verified emails of the CEOs and founders of 9,000+ AI companies.

Shiv Rao’s career timeline

Date

Milestone

Sep 2026

Abridge selected under the VA enterprise contract

Jun 2026

Launches the clinician intelligence platform; Eli Lilly invests

Jun 2025

Raises a $300M Series E at a reported $5.3B

Feb 2025

Raises a $250M Series D at $2.75B

Feb 2024

Raises a $150M Series C at $850M

Aug 2023

Abridge becomes the first Pal in Epic’s partner program

Aug 2022

Takes Abridge to health systems with an enterprise product

Oct 2020

Launches Abridge publicly as an app for patients

2019

Pitches Union Square Ventures, which leads a $5M seed

Feb 2018

Starts Abridge with Sandeep Konam

Before Abridge

Cardiologist at UPMC, where he also led the provider-facing investment portfolio

How Shiv Rao built Abridge

Rao is the son of a Pittsburgh physician. He spent five years of his childhood in Hyderabad, India, then came back to Pittsburgh. Years before Abridge he helped in his father’s cardiology clinic: “I was going into Mercy Hospital in downtown Pittsburgh and just basically being his scribe,” he said in a 2026 talk. He majored in history at Carnegie Mellon before turning to medicine.

As a UPMC cardiologist he spent half his time as a corporate venture capitalist for the health system, and he helped fund a machine learning program at Carnegie Mellon. The paperwork was the problem he wanted to fix: “I became a cardiologist to help my patients improve their health, but the reality was that I was spending more time on my notes than with my patients,” he said in 2022.

He started Abridge with Konam in February 2018. In 2019 he pitched Union Square Ventures on what he called “SoundCloud plus RapGenius for medicine”. The first product, launched in October 2020, helped patients remember their appointments. By 2022 Abridge was selling to health systems, and it went from more than 100 of them in February 2025 to more than 300 by June 2026.

Is Shiv Rao still a doctor?

Yes. Abridge still describes him as a practicing cardiologist, and he told an interviewer in May 2026 that he sees patients one week a month.

Shiv Rao’s education

He earned a BA at Carnegie Mellon, where he majored in history, and completed his medical education and training at the University of Michigan and the University of Pittsburgh School of Medicine.

Shiv Rao’s net worth and age

Forbes and Bloomberg haven’t published a net worth estimate for Rao, and his stake in Abridge isn’t public, so we don’t give a figure. No reliable source publishes his age or year of birth.

In his own words

“We have 100% full control, and that’s super important to me.”

— Shiv Rao on Abridge’s investors, May 2026

“If we can’t actually improve how healthcare is delivered, how it’s experienced, and how it’s paid for, then we haven’t really moved the needle on the problem.”

— Shiv Rao to Fortune, June 2026

“I actually think AI is underhyped.”

— Shiv Rao, May 2026

“Pressure makes diamonds.”

— Shiv Rao on competition from Epic, May 2026

Abridge’s leadership

Person

Role

Shiv Rao, MD

Co-founder and CEO; practicing cardiologist at UPMC

San Oo

Named chief technology officer in May 2026; previously at Slack and Notion

Sagar Sanghvi

Named Abridge’s first chief financial officer in January 2025

Zachary Lipton

Joined as chief scientific officer in February 2023 from Carnegie Mellon and Amazon AI

Tim Hwang

Named general counsel in August 2024

Tina Shah, MD

Named chief clinical officer in September 2023

More on Abridge

Knowledge graph

Everything LeadWave has on Abridge: its leaders, our pages on it and the lists it’s on.

In this dossier

Frequently asked questions

More company dossiers

All dossiers